Table 3.
Summary of the laboratory results of the included studies for meta-analysis.
| Study | Decreased WBC/lymphocytes (%) | Increased WBC/lymphocytes (%) | Increased creatine kinase (%)a | Increased procalcitonin (%) | Increased C-reactive protein (%) | Increased alanine aminotransferase/aspartate transferase (%) |
|---|---|---|---|---|---|---|
| Qiu et al. | 18 (50%) | 0 | 12 (33.3%) | 6 (16.7%) | 1 (2.8%) | 5 (13.9%) |
| Wang et al. | 4 (12.9%) | 7 (22.6%) | 4 (12.9%) | 1 (2.8%) | 3 (9.7%) | 6 (19.4%) |
| Li W. et al. | 0 | 2 (40%) | NA | NA | NA | NA |
| Lu et al. | 51 (29.8%) | 0 | 0 | 105 (61.4%) | 33 (19.3%) | 46 (26.9%) |
| Li X. et al. | 13 (43.3%) | 0 | NA | NA | NA | NA |
| Zheng et al. | 10 (40%) | 0 | 0 | NA | 0 | 0 |
| Feng et al. | 8 (53.3%) | 0 | NA | NA | NA | NA |
| Cai et al. | 1 (10%) | 4 (40%) | 5 (50%) | 0 | 3 (30%) | 3 (30%) |
| Liu H. et al. | 1 (25%) | 2 (50%) | NA | NA | 1 (25%) | NA |
| Zhang et al. | 4 (40%) | 5 (50%) | 8 (80%) | NA | NA | NA |
| Wei et al. | NA | NA | NA | NA | NA | NA |
| Yang et al. | NA | NA | NA | NA | NA | NA |
| Liu M. et al. | 0 | 0 | NA | NA | NA | NA |
| Zhong et al. | 2 (22.2%) | 3 (33.3%) | NA | 0 | 0 | NA |
a
This includes creatine kinase MB.
NA, not available.